KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Non-cash Items (2016 - 2018)

Emergent BioSolutions' Non-cash Items history spans 8 years, with the latest figure at $1.1 million for Q4 2018.

  • For Q4 2018, Non-cash Items fell 97.57% year-over-year to $1.1 million; the TTM value through Dec 2018 reached $1.1 million, down 97.57%, while the annual FY2018 figure was $1.1 million, 97.57% down from the prior year.
  • Non-cash Items reached $1.1 million in Q4 2018 per EBS's latest filing, down from $44.5 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $52.1 million in Q4 2015 to a low of $43156.0 in Q1 2015.
  • Average Non-cash Items over 5 years is $21.2 million, with a median of $22.7 million recorded in 2015.
  • Peak YoY movement for Non-cash Items: crashed 98.01% in 2015, then skyrocketed 1637.54% in 2017.
  • A 5-year view of Non-cash Items shows it stood at $29.2 million in 2014, then skyrocketed by 78.6% to $52.1 million in 2015, then crashed by 51.37% to $25.3 million in 2016, then skyrocketed by 75.55% to $44.5 million in 2017, then plummeted by 97.57% to $1.1 million in 2018.
  • Per Business Quant, the three most recent readings for EBS's Non-cash Items are $1.1 million (Q4 2018), $44.5 million (Q4 2017), and $38.0 million (Q3 2017).